Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Fasshauer

Showing results (51-60 of 171) with videos related to

Pageof 18
Sort By:
Biochemical and Biophysical Research Communications|April 6, 2004
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytesMathias Fasshauer, Johannes Klein, Susan Kralisch, et al.
Diabetes Care|October 20, 2009
Serum levels of the adipokine chemerin in relation to renal functionDörte Pfau, Anette Bachmann, Ulrike Lössner, et al.
Journal of Cellular Biochemistry|November 15, 2008
Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitroGrit Sommer, Sebastian Weise, Susan Kralisch, et al.
Regulatory Peptides|April 29, 2006
Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytesSusan Kralisch, Johannes Klein, Ulrike Lossner, et al.
European Journal of Endocrinology|February 9, 2007
Tissue inhibitor of metalloproteinase-1 predicts adiposity in humansSusan Kralisch, Matthias Bluher, Anke Tonjes, et al.
Molecular and Cellular Endocrinology|July 13, 2005
Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytesSusan Kralisch, Johannes Klein, Ulrike Lossner, et al.
Molecular and Cellular Endocrinology|May 23, 2006
Plasminogen activator inhibitor-1 expression and secretion are stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytesSusan Kralisch, Johannes Klein, Ulrike Lossner, et al.
International Journal of Molecular Sciences|October 2, 2020
Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated LipodystrophySusan Kralisch, Annett Hoffmann, Juliane Estrada-Kunz, et al.
Atherosclerosis|December 7, 2007
Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal diseaseSusan Kralisch, Michaela Ziegelmeier, Anette Bachmann, et al.
Metabolism: Clinical and Experimental|August 17, 2010
Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysisAnne Philipp, Susan Kralisch, Anette Bachmann, et al.
Pageof 18

Showing results (51-60 of 171) with videos related to

Sort By:
Pageof 18
Biochemical and Biophysical Research Communications|April 6, 2004
Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytesMathias Fasshauer, Johannes Klein, Susan Kralisch, et al.
Diabetes Care|October 20, 2009
Serum levels of the adipokine chemerin in relation to renal functionDörte Pfau, Anette Bachmann, Ulrike Lössner, et al.
Journal of Cellular Biochemistry|November 15, 2008
Lipocalin-2 is induced by interleukin-1beta in murine adipocytes in vitroGrit Sommer, Sebastian Weise, Susan Kralisch, et al.
Regulatory Peptides|April 29, 2006
Isoproterenol stimulates monocyte chemoattractant protein-1 expression and secretion in 3T3-L1 adipocytesSusan Kralisch, Johannes Klein, Ulrike Lossner, et al.
European Journal of Endocrinology|February 9, 2007
Tissue inhibitor of metalloproteinase-1 predicts adiposity in humansSusan Kralisch, Matthias Bluher, Anke Tonjes, et al.
Molecular and Cellular Endocrinology|July 13, 2005
Isoproterenol, TNFalpha, and insulin downregulate adipose triglyceride lipase in 3T3-L1 adipocytesSusan Kralisch, Johannes Klein, Ulrike Lossner, et al.
Molecular and Cellular Endocrinology|May 23, 2006
Plasminogen activator inhibitor-1 expression and secretion are stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytesSusan Kralisch, Johannes Klein, Ulrike Lossner, et al.
International Journal of Molecular Sciences|October 2, 2020
Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated LipodystrophySusan Kralisch, Annett Hoffmann, Juliane Estrada-Kunz, et al.
Atherosclerosis|December 7, 2007
Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal diseaseSusan Kralisch, Michaela Ziegelmeier, Anette Bachmann, et al.
Metabolism: Clinical and Experimental|August 17, 2010
Serum levels of the adipokine zinc-α2-glycoprotein are increased in chronic hemodialysisAnne Philipp, Susan Kralisch, Anette Bachmann, et al.
Pageof 18